The Retatrutide Dosing Schedule From Phase 2 Clinical Trials The Phase 2 trial (published in the New England Journal of Medicine) tested four retatrutide dosing schedule arms at target doses of 1mg, 4mg, 8mg, and 12mg weekly
Having an oral formulation, it may lower the psychological barrier that patients have to starting treatment, says Priya Jaisinghani, MD, an endocrinologist and obesity-medicine specialist at New York University Langone Medical Associates and a clinical assistant professor at NYUs Grossman School of Medicine
Expertise in integrative medical weight loss solutions Customized, whole-person care plans, including microdosing when appropriate Access to both branded and compounded GLP-1 options Focus on lasting results and overall health improvement We are here to guide you on your journey to better health not just with medication, but with care that looks at the full picture of your well-being
10 units equal 0.1 mL, and at 5 mg/mL that contains 0.5 mg of peptide
